Inhibiting FST expression in these models has been shown to restore glucose tolerance.[3] Moreover, in obese patients with diabetes undergoing gastric bypass surgery, decreases in serum FST and HbA1c levels have been observed concurrently.[41] This implies that FST may act as a mediator in the development of T2DM. The gene discussed is FST; the disease is type 2 diabetes mellitus.